Contract Signed with Leading Global CRO

AI SummaryClose X

Trellus Health PLC has signed a 12-month contract with a major global Clinical Research Organisation (CRO) to enhance recruitment and enrolment for an immunology and inflammation clinical trial, commencing later this year. The contract includes an upfront fee, monthly management fees, and milestone payments tied to key performance indicators, such as the number of participants opting into the Trellus TrialSetâ„¢ program, increases in qualified participant referrals, and reductions in screen failure rates. Trellus Health has also been granted preferred vendor status by a second leading global CRO, which, while not immediately revenue-generating, provides access to the CRO's client base and accelerates procurement. While this contract does not extend the company's cash runway beyond early December, it signifies progress in securing contracts with leading CROs.

Disclaimer*

UK 100

Latest directors dealings